BILINA 0.5 mg/ml NASAL SPRAY SUSPENSION
How to use BILINA 0.5 mg/ml NASAL SPRAY SUSPENSION
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Leaflet: information for theuser
Bilina0.5 mg/ml nasal spray suspension
Levocabastina
Read the entire leaflet carefully before starting to use this medication, as it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any doubts, consult your doctor or pharmacist.
- This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
- If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
Contents of the leaflet
- What is Bilina and what is it used for
- What you need to know before taking Bilina
- How to use Bilina
- Possible side effects
- Storage of Bilina
- Package contents and additional information
1. What is Bilina and what is it used for
Bilina contains levocabastina, which is an antihistamine used for the symptomatic treatment of allergic rhinitis in adults and in children and adolescents from 4 to less than 18 years of age.
Levocabastina is a highly selective H1 histamine receptor antagonist. After nasal application, it provides rapid and long-lasting relief from allergic rhinitis symptoms (sneezing, nasal itching, and rhinorrhea).
2. What you need to know before taking Bilina
Do not use Bilina
- If you are allergic to levocabastina or any of the other components of this medication (listed in section 6.1).
Warnings and precautions
If you have kidney problems, as levocabastina is primarily excreted through the kidneys. Bilina should be used with caution in patients with renal impairment.
Consult your doctor or pharmacist before starting to use Bilina.
Children and adolescents
- The safety and efficacy of this medication have not been established in children under 4 years of age.
- Bilina should only be used to treat children and adolescents from 4 to less than 18 years of age.
Elderly
Since levocabastina is primarily eliminated through the kidneys and renal function often decreases in the elderly, precautions should be taken when administering Bilina to this group of patients.
Using Bilina with other medications
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, do not use Bilina, as safety studies have not been conducted in pregnant women and Bilina passes into breast milk. Consult your doctor or pharmacist before using this medication.
Driving and using machines
Bilina does not cause sedation or interfere with psychomotor activity. However, if you feel drowsy, avoid driving or operating machines.
Bilina contains benzalkonium chloride and propylene glycol
This medication contains 0.15 mg of benzalkonium chloride per ml of nasal spray suspension.
Benzalkonium chloride may cause irritation or inflammation inside the nose, especially when used for extended periods.
This medication contains 50 mg of propylene glycol per ml of nasal spray suspension.
3. How to use Bilina
Dose
Follow your doctor's instructions for administering this medication exactly. If in doubt, consult your doctor or pharmacist again.
Adults and children and adolescents from 4 to less than 18 years of age
The recommended dose is 2 applications per nostril, twice a day. The dose may be increased to 2 applications, 3 to 4 times a day. Treatment should continue until symptoms are relieved.
Use in children under 4 years of age
The safety and efficacy of this medication have not been established in children under 4 years of age. No data are available.
Elderly
No data are available on the use of levocabastina in the elderly.
Instructions for use
Bilina is a microsuspension. The container should be shaken before each application.
You should clean your nasal passages before administering the medication and inhale it through your nose.
Follow these steps:
- Shake the bottle before removing the cap
- Before using Bilina for the first time, remove the cap and press the bottle one or two times until a fine spray is released
- Blow your nose
- Tilt your head as shown in the image and insert the dosifier into one of the nostrils while pressing the other nostril firmly
- Press the sprayer twice in the nostril while breathing in through that nostril
- Repeat steps 4 and 5 for the other nostril.

.
If you use more Bilina than you should
If you accidentally drink the contents of a container, you may feel drowsy. In this case, it is recommended to drink plenty of non-alcoholic liquids to accelerate renal excretion of the medication and contact your doctor immediately
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to use Bilina
Do not use a double dose to make up for forgotten doses.
If you have any further questions about using this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medications, Bilina can cause side effects, although not everyone will experience them.
The frequency of the possible side effects listed below is defined using the following convention:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from available data)
Headache is the most common side effect with Bilina.
Common side effects (may affect up to 1 in 10 people):
- Nausea
- Fatigue
- Sinusitis
- Drowsiness
- Dizziness
- Sore throat (pharyngolaryngeal pain)
- Nosebleed (epistaxis)
- Cough
- Constant pain
Uncommon side effects (may affect up to 1 in 100 people):
- Irritation, discomfort, pain, burning, or dryness at the application site
- Stuffy nose
- Nasal discomfort
Very rare side effects (may affect up to 1 in 10,000 people):
- Fast and abnormal heartbeats (tachycardia)
- Difficulty breathing
- Hypersensitivity, anaphylaxis (allergic reactions)
- Feeling of general discomfort
- Swelling of the eyelids
- Obstruction of the airways (bronchospasm)
- Palpitations
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency's (AEMPS) online system: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
5. Storage of Bilina
Keep out of sight and reach of children.
Do not use this medication after the expiration date stated on the container after CAD. The expiration date is the last day of the month indicated.
Do not store above 30°C.
Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
6. Package contents and additional information
Composition of Bilina
- The active ingredient is levocabastina. Each milliliter of Bilina contains 0.5 milligrams of levocabastina.
- The other components (excipients) are benzalkonium chloride, propylene glycol, anhydrous disodium phosphate, monosodium phosphate monohydrate, hypromellose, polysorbate 80, disodium edetate, and purified water.
Appearance of the product and package contents
Bilina is a sterile white suspension presented in plastic containers.
Each container contains 10 milliliters of suspension.
Marketing authorization holder and manufacturer
Marketing authorization holder
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona
Spain
Manufacturer
Janssen Pharmaceutica, N.V.
Turnhoutseweg, 30
B-2340 Beerse (Belgium)
Date of last revision of this leaflet: December 2021
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
- Country of registration
- Average pharmacy price6.81 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to BILINA 0.5 mg/ml NASAL SPRAY SUSPENSIONDosage form: NASAL PRODUCT, 0.1 g azelastine hydrochloride/100 mlActive substance: azelastineManufacturer: Cooper Consumer Health B.V.Prescription requiredDosage form: NASAL PRODUCT, 1.5 mg/mlActive substance: azelastineManufacturer: Cooper Consumer Health B.V.Prescription requiredDosage form: NASAL PRODUCT, 1.5 mg/mlActive substance: azelastineManufacturer: Cooper Consumer Health B.V.Prescription required
Online doctors for BILINA 0.5 mg/ml NASAL SPRAY SUSPENSION
Discuss questions about BILINA 0.5 mg/ml NASAL SPRAY SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions